Equival Biocenter

Equival Biocenter is a leading institution in the hospitals and health care sector, dedicated to advancing pharmaceutical research and ensuring the quality and efficacy of medications. Specializing in conducting bioavailability, bioequivalence, and clinical research services, Equival Biocenter plays a crucial role in the development and approval of generic medications. The center's stringent protocols and advanced analytical methods guarantee reliable and precise data, supporting the regulatory registration of medications and contributing to the health and well-being of patients.

Equival Biocenter assists pharmaceutical companies in demonstrating the effectiveness and safety of their products through high-quality bioequivalence studies. Their expertise spans various specialties, including pharmacokinetics, biostatistics, bioanalytical method development, and clinical research. Located at Rue Yahia Layachi, 01, Hussein Dey, Alger, Equival Biocenter is committed to scientific excellence, integrity, and transparency, working closely with regulatory authorities to ensure compliance with both national and international bioequivalence requirements.

With a focus on expanding access to essential treatments while reducing costs, Equival Biocenter serves pharmaceutical companies in Algeria and worldwide. The center's dedication to providing precise and reliable data helps these companies achieve their regulatory objectives and improve overall patient outcomes. Equival Biocenter continues to be a trusted partner in the pharmaceutical industry, driving innovation and ensuring the highest standards of quality. We invite the manager of Equival Biocenter to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development.